Although the function of IFNs other than IFN-α is unclear, the defective therapeutic effect on SLE may be explained by the suppression of IFN-α alone while leaving other active forms, such as IFN-κ and IFN-β. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.